In inflammatory conditions such as inflammatory bowel diseases and arthritis, the serum and tissue levels of IL-17 are increased relative to non-pathological settings where IL-17A levels are extremely low or undetectable [85]. Here, IL17A is linked to inflammatory bowel disease.